Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.38 | N/A |
| PEG Ratio (TTM) | -7.22 | N/A |
| P/S Ratio (TTM) | 2.21 | N/A |
| P/B Ratio (TTM) | 2.09 | N/A |
| P/FCF Ratio (TTM) | 37.97 | N/A |
| Price to 5YR AVG Earnings Ratio | 93.32 | N/A |
| Price to 5YR AVG FCF Ratio | 48.19 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.32% | N/A |
| ROE (TTM) | 11.40% | N/A |
| Net Profit Margin (TTM) | 11.34% | N/A |
| ROIC 5YR AVG | 5.47% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.50% | 194.10% | 199.53% |
| Revenue | 1.06% | 4.70% | 5.60% |
| Net Income | 1.08% | 193.44% | 200.65% |
| Cash Flow | 87.10% | 272.64% | 166.98% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.54 | N/A |
| Quick Ratio (TTM) | 2.41 | N/A |
| D/E Ratio (TTM) | 0.37 | N/A |
| Interest Coverage (TTM) | 7.74 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 2.60 | N/A |
| LTL to 5YR AVG FCF | 9.42 | N/A |
| Shares Outstanding Growth 5YR AVG | 2.69% | N/A |